(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP17A1 mRNA] CTD PMID:31150632 (-)-matairesinol multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 gene SNP affects the susceptibility to [Phytoestrogens results in increased abundance of matairesinol] CTD PMID:16702327 (1->4)-beta-D-glucan multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP17A1 mRNA CTD PMID:36331819 (E)-thiamethoxam decreases expression EXP 6480464 Thiamethoxam results in decreased expression of CYP17A1 mRNA CTD PMID:34181816 (E)-thiamethoxam multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP17A1 mRNA] CTD PMID:34181816 (R)-carnitine multiple interactions EXP 6480464 Carnitine inhibits the reaction [Atrazine results in decreased expression of CYP17A1 mRNA] CTD PMID:29710542 (R,R)-tramadol decreases activity ISO CYP17A1 (Homo sapiens) 6480464 Tramadol results in decreased activity of CYP17A1 protein CTD PMID:29100959 (S)-duloxetine hydrochloride decreases activity ISO CYP17A1 (Homo sapiens) 6480464 Duloxetine Hydrochloride results in decreased activity of CYP17A1 protein CTD PMID:29100959 (S)-duloxetine hydrochloride multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Duloxetine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased hydroxylation of Pregnenolone] which results in increased chemical synthesis of 17-alpha-Hydroxypregnenolone] more ... CTD PMID:29100959 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of CYP17A1 mRNA and Nicotine results in decreased expression of CYP17A1 protein CTD PMID:27782041 and PMID:28986172 (S)-nicotine decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Nicotine results in decreased expression of CYP17A1 mRNA CTD PMID:24709674 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane decreases expression ISO Cyp17a1 (Mus musculus) 6480464 2 more ... CTD PMID:11509743 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane decreases activity EXP 6480464 2 more ... CTD PMID:24451217 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane decreases activity ISO CYP17A1 (Homo sapiens) 6480464 2 more ... CTD PMID:24451217 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Estradiol co-treated with 2 more ... CTD PMID:11509743 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane decreases expression ISO Cyp17a1 (Mus musculus) 6480464 1 more ... CTD PMID:20840852 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression EXP 6480464 o and p'-DDT affects the expression of CYP17A1 mRNA CTD PMID:17984292 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO Cyp17a1 (Mus musculus) 6480464 o and p'-DDT affects the expression of CYP17A1 mRNA CTD PMID:18925944 1,2-dichloroethane affects expression ISO Cyp17a1 (Mus musculus) 6480464 ethylene dichloride affects the expression of CYP17A1 mRNA CTD PMID:28973639 1,3,4-oxadiazoles decreases activity EXP 6480464 1 more ... CTD PMID:25993309 1,3-dinitrobenzene decreases expression ISO CYP17A1 (Homo sapiens) 6480464 3-dinitrobenzene results in decreased expression of CYP17A1 mRNA CTD PMID:22841810 1-methylnicotinamide multiple interactions EXP 6480464 N(1)-methylnicotinamide inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA] CTD PMID:32298659 1-naphthylamine decreases expression ISO CYP17A1 (Homo sapiens) 6480464 1-Naphthylamine results in decreased expression of CYP17A1 mRNA CTD PMID:31100596 16-Hydroxyprogesterone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [CYP17A1 protein results in increased hydroxylation of Progesterone] which results in increased chemical synthesis of 16-hydroxyprogesterone CTD PMID:17194026 17alpha-ethynylestradiol multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [Ethinyl Estradiol co-treated with drospirenone] results in decreased activity of CYP17A1 protein CTD PMID:17418832 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CYP17A1 mRNA CTD PMID:12655037 more ... 17alpha-ethynylestradiol increases expression ISO Cyp17a1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of CYP17A1 mRNA CTD PMID:12072388 17alpha-ethynylestradiol affects expression ISO Cyp17a1 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of CYP17A1 mRNA CTD PMID:14976129 17alpha-hydroxypregnenolone affects chemical synthesis ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the chemical synthesis of 17-alpha-Hydroxypregnenolone CTD PMID:16030167 17alpha-hydroxypregnenolone increases metabolic processing ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxypregnenolone CTD PMID:29100959 17alpha-hydroxypregnenolone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [[abiraterone results in decreased activity of CYP17A1 protein] which results in decreased hydroxylation of Pregnenolone] which results in increased chemical synthesis of 17-alpha-Hydroxypregnenolone more ... CTD PMID:17194026 and PMID:29100959 17alpha-hydroxypregnenolone decreases acetylation ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein results in decreased acetylation of 17-alpha-Hydroxypregnenolone CTD PMID:15562394 17alpha-hydroxypregnenolone affects metabolic processing ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the metabolism of 17-alpha-Hydroxypregnenolone CTD PMID:16030167 17alpha-hydroxyprogesterone affects abundance ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the abundance of 17-alpha-Hydroxyprogesterone CTD PMID:21427057 17alpha-hydroxyprogesterone increases metabolic processing ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxyprogesterone CTD PMID:29100959 17alpha-hydroxyprogesterone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [[abiraterone results in decreased activity of CYP17A1 protein] which results in decreased hydroxylation of Progesterone] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone more ... CTD PMID:16030167 more ... 17alpha-hydroxyprogesterone affects metabolic processing ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the metabolism of 17-alpha-Hydroxyprogesterone CTD PMID:16030167 17alpha-hydroxyprogesterone affects chemical synthesis ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the chemical synthesis of 17-alpha-Hydroxyprogesterone CTD PMID:16030167 17beta-estradiol multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Estradiol co-treated with 2 more ... CTD PMID:11509743 more ... 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of CYP17A1 mRNA CTD PMID:32145629 and PMID:36931579 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CYP17A1 mRNA and Fulvestrant inhibits the reaction [Estradiol affects the expression of CYP17A1 mRNA] CTD PMID:26496021 and PMID:36931579 17beta-estradiol increases expression ISO Cyp17a1 (Mus musculus) 6480464 Estradiol results in increased expression of CYP17A1 mRNA CTD PMID:18281260 more ... 17beta-estradiol decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Estradiol results in decreased expression of CYP17A1 mRNA and Estradiol results in decreased expression of CYP17A1 protein CTD PMID:11509743 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP17A1 mRNA and Estradiol results in decreased expression of CYP17A1 protein CTD PMID:20144698 17beta-estradiol 3-benzoate decreases expression EXP 6480464 estradiol 3-benzoate results in decreased expression of CYP17A1 protein CTD PMID:24752506 1H-pyrazole decreases expression ISO Cyp17a1 (Mus musculus) 6480464 pyrazole results in decreased expression of CYP17A1 mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO CYP17A1 (Homo sapiens) 6480464 2 more ... CTD PMID:18248924 2,2',4,4'-Tetrabromodiphenyl ether decreases activity ISO CYP17A1 (Homo sapiens) 6480464 2 more ... CTD PMID:16828825 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,4,7,8-Pentachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,3,7,8-tetrabromodibenzodioxine decreases expression ISO CYP17A1 (Homo sapiens) 6480464 2 more ... CTD PMID:17447562 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Gonadotropins and Equine inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA] CTD PMID:19276399 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cyp17a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CYP17A1 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP17A1 gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA and Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 protein CTD PMID:16254025 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP17A1 mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP17A1 mRNA CTD PMID:22298810 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 and PMID:32109520 2,4,6-tribromophenol decreases expression ISO CYP17A1 (Homo sapiens) 6480464 2 more ... CTD PMID:17447562 2,4-D affects expression ISO Cyp17a1 (Mus musculus) 6480464 2 and 4-Dichlorophenoxyacetic Acid affects the expression of CYP17A1 mRNA CTD PMID:26838045 2,4-dibromophenol increases expression ISO CYP17A1 (Homo sapiens) 6480464 2 and 4-dibromophenol results in increased expression of CYP17A1 mRNA CTD PMID:17447562 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of CYP17A1 mRNA CTD PMID:21346803 2,6-dibromophenol decreases expression ISO CYP17A1 (Homo sapiens) 6480464 2 and 6-dibromophenol results in decreased expression of CYP17A1 mRNA CTD PMID:17447562 2-bromophenol increases expression ISO CYP17A1 (Homo sapiens) 6480464 2-bromophenol results in increased expression of CYP17A1 mRNA CTD PMID:17447562 2-methoxyethanol decreases expression EXP 6480464 methyl cellosolve results in decreased expression of CYP17A1 mRNA CTD PMID:21061450 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions EXP 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CYP17A1 mRNA] CTD PMID:21918126 2-trans,6-trans-farnesyl diphosphate multiple interactions EXP 6480464 farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CYP17A1 mRNA] CTD PMID:21918126 3',5'-cyclic AMP multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [acetyl methyl tetramethyl tetralin co-treated with Cyclic AMP] results in decreased activity of CYP17A1 protein more ... CTD PMID:23084589 3',5'-cyclic AMP increases expression ISO Cyp17a1 (Mus musculus) 6480464 Cyclic AMP results in increased expression of CYP17A1 mRNA CTD PMID:25576683 3,3',4,4',5-pentachlorobiphenyl decreases activity ISO CYP17A1 (Homo sapiens) 6480464 3 more ... CTD PMID:15703266 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 and PMID:34256052 3,3',4,4',5-pentachlorobiphenyl increases expression ISO CYP17A1 (Homo sapiens) 6480464 3 more ... CTD PMID:16216300 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO CYP17A1 (Homo sapiens) 6480464 3 more ... CTD PMID:15703266 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Cyp17a1 (Mus musculus) 6480464 3 more ... CTD PMID:12781204 3,3',5,5'-tetrabromobisphenol A increases expression ISO Cyp17a1 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of CYP17A1 mRNA CTD PMID:24014645 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Cyp17a1 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of CYP17A1 mRNA CTD PMID:35230478 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of CYP17A1 mRNA CTD PMID:26988606 3,3',5-triiodo-L-thyronine multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 2 more ... CTD PMID:21726595 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol decreases expression ISO CYP17A1 (Homo sapiens) 6480464 fluorotelomer alcohols results in decreased expression of CYP17A1 mRNA and fluorotelomer alcohols results in decreased expression of CYP17A1 protein CTD PMID:20615422 3,4-dichloroaniline decreases expression ISO CYP17A1 (Homo sapiens) 6480464 3 and 4-dichloroaniline results in decreased expression of CYP17A1 mRNA CTD PMID:31100596 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of CYP17A1 mRNA CTD PMID:35063618 3-methylcholanthrene affects expression ISO Cyp17a1 (Mus musculus) 6480464 Methylcholanthrene affects the expression of CYP17A1 mRNA CTD PMID:35487396 3alpha-hydroxy-5beta-pregnan-20-one increases hydroxylation ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein results in increased hydroxylation of Pregnanolone analog CTD PMID:14522586 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of CYP17A1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression ISO CYP17A1 (Homo sapiens) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of CYP17A1 mRNA CTD PMID:31100596 4,4'-sulfonyldiphenol increases expression ISO Cyp17a1 (Mus musculus) 6480464 bisphenol S results in increased expression of CYP17A1 mRNA CTD PMID:25576683 and PMID:30196065 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of CYP17A1 mRNA and bisphenol S results in decreased expression of CYP17A1 protein CTD PMID:37357847 4,4'-sulfonyldiphenol affects methylation ISO Cyp17a1 (Mus musculus) 6480464 bisphenol S affects the methylation of CYP17A1 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases methylation ISO Cyp17a1 (Mus musculus) 6480464 bisphenol S results in increased methylation of CYP17A1 exon CTD PMID:33297965 4,4'-sulfonyldiphenol decreases expression ISO Cyp17a1 (Mus musculus) 6480464 bisphenol S results in decreased expression of CYP17A1 mRNA and bisphenol S results in decreased expression of CYP17A1 protein CTD PMID:31132128 more ... 4,4'-sulfonyldiphenol decreases expression ISO CYP17A1 (Homo sapiens) 6480464 bisphenol S results in decreased expression of CYP17A1 mRNA CTD PMID:26751127 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile decreases activity ISO CYP17A1 (Homo sapiens) 6480464 Fadrozole results in decreased activity of CYP17A1 protein CTD PMID:15743198 and PMID:15771425 4-nitro-m-cresol increases expression ISO Cyp17a1 (Mus musculus) 6480464 4-nitro-3-cresol results in increased expression of CYP17A1 mRNA CTD PMID:35654127 4-nonylphenol multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CYP17A1 mRNA CTD PMID:29029336 4-nonylphenol decreases expression ISO Cyp17a1 (Mus musculus) 6480464 4-nonylphenol results in decreased expression of CYP17A1 mRNA CTD PMID:29029336 4-octylphenol decreases expression EXP 6480464 4-octylphenol results in decreased expression of CYP17A1 protein CTD PMID:9361775 4-tert-Octylphenol decreases expression ISO Cyp17a1 (Mus musculus) 6480464 4-tert-octylphenol results in decreased expression of CYP17A1 mRNA CTD PMID:17696135 4-tert-Octylphenol multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CYP17A1 mRNA CTD PMID:29029336 5alpha-pregnane-3,20-dione increases hydroxylation ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein results in increased hydroxylation of 5-alpha-Dihydroprogesterone CTD PMID:14522586 8-Br-cAMP multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 2 more ... CTD PMID:21610156 and PMID:21726595 8-Br-cAMP increases expression ISO Cyp17a1 (Mus musculus) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA and 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 protein CTD PMID:21726595 and PMID:24014645 8-Br-cAMP increases expression ISO CYP17A1 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA CTD PMID:22079614 more ... 8-Br-cAMP multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [4-nitro-3-phenylphenol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of CYP17A1 protein more ... CTD PMID:18336853 more ... abiraterone decreases activity EXP 6480464 abiraterone results in decreased activity of CYP17A1 protein CTD PMID:25993309 abiraterone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [[abiraterone results in decreased activity of CYP17A1 protein] which results in decreased hydroxylation of Pregnenolone] which results in increased chemical synthesis of 17-alpha-Hydroxypregnenolone more ... CTD PMID:29100959 abiraterone decreases activity ISO CYP17A1 (Homo sapiens) 6480464 abiraterone analog results in decreased activity of CYP17A1 protein and abiraterone results in decreased activity of CYP17A1 protein CTD PMID:17194026 and PMID:29100959 acetaldehyde multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [CGA protein results in increased abundance of Acetaldehyde] which results in increased expression of CYP17A1 mRNA CTD PMID:22285649 acetamide affects expression EXP 6480464 acetamide affects the expression of CYP17A1 mRNA CTD PMID:31881176 acetamiprid decreases expression ISO Cyp17a1 (Mus musculus) 6480464 acetamiprid results in decreased expression of CYP17A1 mRNA CTD PMID:30103633 Acetyl tributyl citrate decreases expression ISO CYP17A1 (Homo sapiens) 6480464 2-acetyltributylcitrate results in decreased expression of CYP17A1 mRNA CTD PMID:28235592 aconitine decreases expression EXP 6480464 Aconitine results in decreased expression of CYP17A1 mRNA CTD PMID:31499053 acrylamide multiple interactions EXP 6480464 naringin inhibits the reaction [Acrylamide results in decreased expression of CYP17A1 mRNA] CTD PMID:36598108 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CYP17A1 mRNA CTD PMID:36598108 acrylamide decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Acrylamide results in decreased expression of CYP17A1 mRNA and Acrylamide results in decreased expression of CYP17A1 protein CTD PMID:36565847 aflatoxin B1 decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of CYP17A1 mRNA CTD PMID:19770486 albuterol increases expression ISO CYP17A1 (Homo sapiens) 6480464 Albuterol results in increased expression of CYP17A1 CTD PMID:17822730 alginic acid increases expression ISO Cyp17a1 (Mus musculus) 6480464 Alginic Acid results in increased expression of CYP17A1 protein CTD PMID:35066102 all-trans-retinoic acid increases expression ISO CYP17A1 (Homo sapiens) 6480464 Tretinoin results in increased expression of CYP17A1 mRNA CTD PMID:16621909 all-trans-retinoic acid multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 Tretinoin inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased expression of CYP17A1 mRNA] CTD PMID:22285649 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of CYP17A1 mRNA CTD PMID:14960491 allethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP17A1 mRNA more ... CTD PMID:33051911 more ... alpha-naphthoflavone decreases expression ISO CYP17A1 (Homo sapiens) 6480464 alpha-naphthoflavone results in decreased expression of CYP17A1 mRNA CTD PMID:24875446 alternariol increases expression ISO CYP17A1 (Homo sapiens) 6480464 alternariol results in increased expression of CYP17A1 mRNA CTD PMID:23665424 aminoglutethimide decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Aminoglutethimide results in decreased expression of CYP17A1 mRNA CTD PMID:16935330 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP17A1 mRNA CTD PMID:16483693 amoxicillin decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Amoxicillin results in decreased expression of CYP17A1 mRNA CTD PMID:36529298 androgen antagonist multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CYP17A1 mRNA and [Pesticides co-treated with Phthalic Acids co-treated with Androgen Antagonists] results in decreased expression of CYP17A1 mRNA CTD PMID:25607892 and PMID:29945228 andrographolide multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CYP17A1 mRNA CTD PMID:19737545 androst-4-ene-3,17-dione decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Androstenedione results in decreased expression of CYP17A1 mRNA CTD PMID:15625562 androst-4-ene-3,17-dione affects chemical synthesis ISO Cyp17a1 (Mus musculus) 6480464 CYP17A1 protein affects the chemical synthesis of Androstenedione CTD PMID:15555913 androst-4-ene-3,17-dione multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [CYP17A1 gene SNP affects the susceptibility to perfluorooctane sulfonic acid] which affects the abundance of Androstenedione more ... CTD PMID:16030167 more ... androst-4-ene-3,17-dione affects chemical synthesis ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the chemical synthesis of Androstenedione CTD PMID:14522586 more ... androst-4-ene-3,17-dione affects abundance ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the abundance of Androstenedione CTD PMID:21427057 androsterone affects chemical synthesis ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the chemical synthesis of Androsterone CTD PMID:14522586 antalarmin decreases expression ISO CYP17A1 (Homo sapiens) 6480464 antalarmin results in decreased expression of CYP17A1 mRNA CTD PMID:16014403 anthra[1,9-cd]pyrazol-6(2H)-one increases expression ISO CYP17A1 (Homo sapiens) 6480464 pyrazolanthrone results in increased expression of CYP17A1 mRNA CTD PMID:16269825 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 mRNA] and pyrazolanthrone inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 protein] CTD PMID:29567110 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [FGF19 protein results in decreased expression of CYP17A1 mRNA] CTD PMID:16269825 apigenin multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Apigenin inhibits the reaction [Colforsin results in increased expression of CYP17A1 mRNA] CTD PMID:23370353 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP17A1 mRNA and Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP17A1 protein CTD PMID:29208485 arsane affects metabolic processing ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the metabolism of Arsenic CTD PMID:18682255 arsenic atom affects metabolic processing ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the metabolism of Arsenic CTD PMID:18682255 arsenous acid decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of CYP17A1 mRNA CTD PMID:18630931 astressin decreases expression ISO CYP17A1 (Homo sapiens) 6480464 astressin results in decreased expression of CYP17A1 mRNA CTD PMID:16014403 atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of CYP17A1 mRNA CTD PMID:29574565 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of CYP17A1 mRNA CTD PMID:19541795 and PMID:29710542 atrazine increases expression ISO Cyp17a1 (Mus musculus) 6480464 Atrazine results in increased expression of CYP17A1 mRNA CTD PMID:36831314 atrazine decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Atrazine results in decreased expression of CYP17A1 mRNA CTD PMID:23376530 more ... atrazine increases expression EXP 6480464 Atrazine results in increased expression of CYP17A1 mRNA and Atrazine results in increased expression of CYP17A1 protein CTD PMID:20667998 and PMID:23200735 atrazine multiple interactions EXP 6480464 [Atrazine co-treated with Bucladesine] results in increased expression of CYP17A1 mRNA more ... CTD PMID:23200735 and PMID:29710542 benomyl decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Benomyl results in decreased expression of CYP17A1 mRNA CTD PMID:25324206 benomyl multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Benomyl results in decreased expression of and results in decreased activity of CYP17A1 protein CTD PMID:25324206 benzene decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Benzene results in decreased expression of CYP17A1 mRNA CTD PMID:34624356 benzo[a]pyrene decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CYP17A1 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO CYP17A1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CYP17A1 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYP17A1 mRNA CTD PMID:27858113 benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of CYP17A1 mRNA CTD PMID:22960446 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CYP17A1 mRNA and Benzo(a)pyrene results in decreased expression of CYP17A1 protein CTD PMID:21737371 benzo[b]fluoranthene multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYP17A1 mRNA CTD PMID:27858113 berberine multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 Berberine inhibits the reaction [Dexamethasone results in increased expression of CYP17A1 mRNA] CTD PMID:20462044 beta-damascenone increases expression ISO Cyp17a1 (Mus musculus) 6480464 beta-damascenone results in increased expression of CYP17A1 mRNA CTD PMID:22982537 beta-naphthoflavone multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CYP17A1 mRNA CTD PMID:19737545 bexarotene multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of CYP17A1 mRNA CTD PMID:17630414 bifenthrin decreases expression ISO Cyp17a1 (Mus musculus) 6480464 bifenthrin results in decreased expression of CYP17A1 mRNA CTD PMID:23994515 more ... bifenthrin decreases expression ISO CYP17A1 (Homo sapiens) 6480464 bifenthrin results in decreased expression of CYP17A1 mRNA CTD PMID:34896276 bifenthrin multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA] CTD PMID:34896276 bifenthrin increases expression ISO CYP17A1 (Homo sapiens) 6480464 bifenthrin results in increased expression of CYP17A1 mRNA CTD PMID:24938463 bifenthrin increases expression ISO Cyp17a1 (Mus musculus) 6480464 bifenthrin results in increased expression of CYP17A1 mRNA CTD PMID:26071804 bis(2-ethylhexyl) phthalate multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CYP17A1 mRNA and [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:29029336 and PMID:30802670 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA more ... CTD PMID:29777495 more ... bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of CYP17A1 mRNA and Diethylhexyl Phthalate results in decreased expression of CYP17A1 protein CTD PMID:26472102 more ... bis(2-ethylhexyl) phthalate decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of CYP17A1 mRNA and Diethylhexyl Phthalate results in decreased expression of CYP17A1 protein CTD PMID:25701202 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CYP17A1 mRNA more ... CTD PMID:14605012 more ... bisphenol A affects response to substance ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 gene SNP affects the susceptibility to bisphenol A CTD PMID:34426286 bisphenol A increases expression ISO CYP17A1 (Homo sapiens) 6480464 bisphenol A results in increased expression of CYP17A1 mRNA and bisphenol A results in increased expression of CYP17A1 protein CTD PMID:34537452 bisphenol A multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [bisphenol A results in increased expression of CYP17A1 mRNA] and Fulvestrant inhibits the reaction [bisphenol A results in increased expression of CYP17A1 protein] CTD PMID:34537452 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP17A1 mRNA CTD PMID:32145629 bisphenol A multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 bisphenol A promotes the reaction [Estradiol results in increased expression of CYP17A1 mRNA] and bisphenol A promotes the reaction [Estradiol results in increased expression of CYP17A1 protein] CTD PMID:28476547 bisphenol A affects expression ISO Cyp17a1 (Mus musculus) 6480464 bisphenol A affects the expression of CYP17A1 mRNA and bisphenol A affects the expression of CYP17A1 protein CTD PMID:28476547 bisphenol A decreases expression ISO Cyp17a1 (Mus musculus) 6480464 bisphenol A results in decreased expression of CYP17A1 mRNA CTD PMID:21182934 more ... bisphenol A decreases expression ISO CYP17A1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of CYP17A1 mRNA CTD PMID:26751127 bisphenol A increases expression ISO Cyp17a1 (Mus musculus) 6480464 bisphenol A results in increased expression of CYP17A1 mRNA CTD PMID:17706920 more ... bisphenol A decreases expression EXP 6480464 bisphenol A analog results in decreased expression of CYP17A1 mRNA more ... CTD PMID:14605012 more ... bisphenol A decreases activity EXP 6480464 bisphenol A results in decreased activity of CYP17A1 protein CTD PMID:21925253 bisphenol A decreases activity ISO CYP17A1 (Homo sapiens) 6480464 bisphenol A results in decreased activity of CYP17A1 protein CTD PMID:21427057 and PMID:21925253 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP17A1 mRNA and bisphenol A results in increased expression of CYP17A1 protein CTD PMID:18191889 more ... Bisphenol B decreases expression EXP 6480464 bisphenol B results in decreased expression of CYP17A1 mRNA CTD PMID:33940105 bisphenol F decreases expression ISO CYP17A1 (Homo sapiens) 6480464 4 and 4'-bisphenol F results in decreased expression of CYP17A1 mRNA CTD PMID:26751127 bisphenol F increases expression ISO Cyp17a1 (Mus musculus) 6480464 4 and 4'-bisphenol F results in increased expression of CYP17A1 mRNA CTD PMID:30196065 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of CYP17A1 mRNA CTD PMID:32479839 bucladesine decreases expression EXP 6480464 Bucladesine results in decreased expression of CYP17A1 mRNA CTD PMID:21693180 bucladesine increases expression ISO CYP17A1 (Homo sapiens) 6480464 Bucladesine results in increased expression of CYP17A1 mRNA CTD PMID:35987080 bucladesine multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 fluorene-9-bisphenol inhibits the reaction [Bucladesine results in increased expression of CYP17A1 mRNA] CTD PMID:35987080 bucladesine increases expression EXP 6480464 Bucladesine results in increased expression of CYP17A1 mRNA CTD PMID:21458522 bucladesine multiple interactions EXP 6480464 [Atrazine co-treated with Bucladesine] results in increased expression of CYP17A1 mRNA and Quercetin inhibits the reaction [[Atrazine co-treated with Bucladesine] results in increased expression of CYP17A1 mRNA] CTD PMID:23200735 butylated hydroxyanisole decreases activity EXP 6480464 Butylated Hydroxyanisole results in decreased activity of CYP17A1 protein CTD PMID:27388148 Butylbenzyl phthalate multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CYP17A1 mRNA and [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:29029336 and PMID:30802670 Butylbenzyl phthalate multiple interactions EXP 6480464 [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:37788136 Butylbenzyl phthalate decreases expression EXP 6480464 butylbenzyl phthalate results in decreased expression of CYP17A1 mRNA CTD PMID:26472102 and PMID:33983380 Butylparaben multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CYP17A1 mRNA CTD PMID:25607892 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of CYP17A1 mRNA CTD PMID:19167457 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CYP17A1 protein and [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP17A1 mRNA CTD PMID:31654709 cadmium atom multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYP17A1 mRNA CTD PMID:37325564 cadmium dichloride decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of CYP17A1 mRNA and Cadmium Chloride results in decreased expression of CYP17A1 protein CTD PMID:19897027 and PMID:24982889 cadmium dichloride multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYP17A1 mRNA CTD PMID:37325564 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CYP17A1 protein and [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP17A1 mRNA CTD PMID:31654709 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CYP17A1 mRNA and Cadmium Chloride results in decreased expression of CYP17A1 protein CTD PMID:25993096 and PMID:29214744 caffeine increases expression EXP 6480464 Caffeine results in increased expression of CYP17A1 mRNA CTD PMID:25868845 carbamazepine decreases activity ISO CYP17A1 (Homo sapiens) 6480464 Carbamazepine results in decreased activity of CYP17A1 protein CTD PMID:15730543 carbamazepine decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Carbamazepine results in decreased expression of CYP17A1 mRNA CTD PMID:19566492 carbon nanotube decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Nanotubes and Carbon co-treated with Dibutyl Phthalate] affects the expression of CYP17A1 mRNA CTD PMID:37505531 cetrorelix multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of CYP17A1 mRNA and [cetrorelix co-treated with testosterone enanthate] results in decreased expression of CYP17A1 mRNA CTD PMID:18160741 chenodeoxycholic acid decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Chenodeoxycholic Acid results in decreased expression of CYP17A1 mRNA CTD PMID:22961653 chenodeoxycholic acid multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 NR1H4 protein promotes the reaction [Chenodeoxycholic Acid results in decreased expression of CYP17A1 mRNA] CTD PMID:22961653 chlordecone increases expression ISO Cyp17a1 (Mus musculus) 6480464 Chlordecone results in increased expression of CYP17A1 mRNA CTD PMID:33711761 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of CYP17A1 mRNA CTD PMID:30744511 chloroquine decreases expression EXP 6480464 Chloroquine results in decreased expression of CYP17A1 mRNA CTD PMID:19393257 chlorpyrifos decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of CYP17A1 mRNA CTD PMID:30378422 and PMID:37019170 cholesterol affects chemical synthesis ISO Cyp17a1 (Mus musculus) 6480464 CYP17A1 protein affects the chemical synthesis of Cholesterol CTD PMID:15761033 Chorionic gonadotropin increases expression EXP 6480464 Chorionic Gonadotropin results in increased expression of CYP17A1 mRNA CTD PMID:15930178 Chorionic gonadotropin multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [Gonadotropins and Equine co-treated with Chorionic Gonadotropin] results in increased expression of CYP17A1 mRNA CTD PMID:28648634 chromium(6+) multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CYP17A1 protein CTD PMID:33675932 chrysene multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYP17A1 mRNA CTD PMID:27858113 clofibrate multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP17A1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP17A1 mRNA] CTD PMID:17585979 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of CYP17A1 mRNA CTD PMID:33983380 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CYP17A1 mRNA CTD PMID:15033592 clofibrate decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Clofibrate results in decreased expression of CYP17A1 mRNA CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP17A1 mRNA CTD PMID:17602206 clotrimazole decreases activity ISO CYP17A1 (Homo sapiens) 6480464 Clotrimazole results in decreased activity of CYP17A1 protein CTD PMID:31330226 colforsin daropate hydrochloride increases expression ISO CYP17A1 (Homo sapiens) 6480464 Colforsin results in increased expression of CYP17A1 mRNA CTD PMID:15625562 more ... colforsin daropate hydrochloride increases expression ISO Cyp17a1 (Mus musculus) 6480464 Colforsin results in increased expression of CYP17A1 mRNA CTD PMID:22461451 colforsin daropate hydrochloride multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [Colforsin co-treated with triptolide] results in decreased expression of CYP17A1 mRNA more ... CTD PMID:15625562 more ... corn oil affects expression EXP 6480464 Corn Oil affects the expression of CYP17A1 mRNA CTD PMID:16360708 corticotropin affects abundance ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the abundance of Adrenocorticotropic Hormone CTD PMID:18645707 cyanamide multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 Cyanamide inhibits the reaction [CGA protein results in increased expression of CYP17A1 mRNA] CTD PMID:22285649 cyclosporin A decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Cyclosporine results in decreased expression of CYP17A1 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CYP17A1 mRNA CTD PMID:25562108 cyhalothrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP17A1 mRNA more ... CTD PMID:33051911 more ... cypermethrin decreases expression ISO Cyp17a1 (Mus musculus) 6480464 cypermethrin results in decreased expression of CYP17A1 mRNA and cypermethrin results in decreased expression of CYP17A1 protein CTD PMID:21397294 more ... cypermethrin affects expression EXP 6480464 cypermethrin affects the expression of CYP17A1 mRNA CTD PMID:35605701 cypermethrin decreases expression EXP 6480464 cypermethrin results in decreased expression of CYP17A1 mRNA and cypermethrin results in decreased expression of CYP17A1 protein CTD PMID:35102696 cypermethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP17A1 mRNA more ... CTD PMID:33051911 more ... DDE multiple interactions EXP 6480464 [Pesticides co-treated with Dichlorodiphenyl Dichloroethylene co-treated with Phthalic Acids] results in decreased expression of CYP17A1 mRNA CTD PMID:34000504 DDT multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 fulvestrant inhibits the reaction [DDT results in increased expression of CYP17A1 mRNA] CTD PMID:23684557 DDT increases expression ISO Cyp17a1 (Mus musculus) 6480464 DDT results in increased expression of CYP17A1 mRNA CTD PMID:23684557 decabromodiphenyl ether decreases activity EXP 6480464 decabromobiphenyl ether results in decreased activity of CYP17A1 protein CTD PMID:18495385 dehydroepiandrosterone affects chemical synthesis ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the chemical synthesis of Dehydroepiandrosterone CTD PMID:15562394 and PMID:16030167 dehydroepiandrosterone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxypregnenolone] which results in increased chemical synthesis of Dehydroepiandrosterone more ... CTD PMID:29100959 dehydroepiandrosterone affects metabolic processing EXP 6480464 CYP17A1 protein affects the metabolism of Dehydroepiandrosterone CTD PMID:15261307 dehydroepiandrosterone affects chemical synthesis ISO Cyp17a1 (Mus musculus) 6480464 CYP17A1 protein affects the chemical synthesis of Dehydroepiandrosterone CTD PMID:15666818 dehydroepiandrosterone affects chemical synthesis EXP 6480464 CYP17A1 protein affects the chemical synthesis of Dehydroepiandrosterone CTD PMID:15934942 dehydroepiandrosterone decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Dehydroepiandrosterone results in decreased expression of CYP17A1 mRNA CTD PMID:15625562 deoxynivalenol increases expression ISO CYP17A1 (Homo sapiens) 6480464 deoxynivalenol results in increased expression of CYP17A1 mRNA CTD PMID:22982764 desogestrel multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of CYP17A1 mRNA CTD PMID:18160741 dexamethasone multiple interactions EXP 6480464 [Dexamethasone co-treated with Dibutyl Phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:22615892 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CYP17A1 mRNA CTD PMID:29902490 and PMID:33983380 dexamethasone multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 Berberine inhibits the reaction [Dexamethasone results in increased expression of CYP17A1 mRNA] CTD PMID:20462044 dexamethasone increases expression ISO Cyp17a1 (Mus musculus) 6480464 Dexamethasone results in increased expression of CYP17A1 mRNA CTD PMID:20462044 dextran sulfate decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Dextran Sulfate results in decreased expression of CYP17A1 mRNA CTD PMID:35093514 Di-n-hexyl phthalate decreases expression EXP 6480464 di-n-hexyl phthalate results in decreased expression of CYP17A1 mRNA and di-n-hexyl phthalate results in decreased expression of CYP17A1 protein CTD PMID:22112501 more ... diarsenic trioxide decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of CYP17A1 mRNA CTD PMID:18630931 dibromoacetic acid decreases expression EXP 6480464 dibromoacetic acid results in decreased expression of CYP17A1 mRNA CTD PMID:21046364 dibutyl phthalate multiple interactions EXP 6480464 [Dexamethasone co-treated with Dibutyl Phthalate] results in decreased expression of CYP17A1 mRNA more ... CTD PMID:17884934 more ... dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA and Dibutyl Phthalate results in decreased expression of CYP17A1 protein CTD PMID:14617579 more ... dibutyl phthalate multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CYP17A1 mRNA more ... CTD PMID:29029336 more ... dibutyl phthalate increases expression ISO Cyp17a1 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of CYP17A1 mRNA CTD PMID:25765776 dibutyl phthalate decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA CTD PMID:22511013 diclofenac increases expression ISO Cyp17a1 (Mus musculus) 6480464 Diclofenac results in increased expression of CYP17A1 mRNA CTD PMID:26934552 Dicyclohexyl phthalate decreases expression EXP 6480464 dicyclohexyl phthalate results in decreased expression of CYP17A1 mRNA and dicyclohexyl phthalate results in decreased expression of CYP17A1 protein CTD PMID:30391266 and PMID:33983380 dienestrol multiple interactions EXP 6480464 [Dienestrol co-treated with Flutamide] results in increased expression of CYP17A1 mRNA CTD PMID:32738380 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP17A1 mRNA and diethyl phthalate inhibits the reaction [NR5A1 binds to CYP17A1 promoter] CTD PMID:17884934 and PMID:33983380 diethyl phthalate multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:30802670 diethyl phthalate decreases expression EXP 6480464 diethyl phthalate results in decreased expression of CYP17A1 mRNA CTD PMID:29325824 diethylstilbestrol affects expression ISO Cyp17a1 (Mus musculus) 6480464 Diethylstilbestrol affects the expression of CYP17A1 mRNA and Diethylstilbestrol affects the expression of CYP17A1 protein CTD PMID:15196701 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of CYP17A1 mRNA and Diethylstilbestrol results in decreased expression of CYP17A1 protein CTD PMID:22615892 more ... difenoconazole increases expression ISO Cyp17a1 (Mus musculus) 6480464 difenoconazole results in increased expression of CYP17A1 mRNA CTD PMID:34425431 diheptyl phthalate decreases expression EXP 6480464 diheptyl phthalate results in decreased expression of CYP17A1 mRNA CTD PMID:22112501 and PMID:33983380 diisobutyl phthalate decreases expression EXP 6480464 diisobutyl phthalate results in decreased expression of CYP17A1 mRNA CTD PMID:22112501 more ... diisobutyl phthalate multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:30802670 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP17A1 mRNA and [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:33983380 and PMID:37788136 diisononyl phthalate decreases expression EXP 6480464 diisononyl phthalate results in decreased expression of CYP17A1 mRNA CTD PMID:22112501 and PMID:25445723 diisononyl phthalate multiple interactions EXP 6480464 [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:37788136 diisononyl phthalate multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:30802670 dipentyl phthalate multiple interactions EXP 6480464 [Simvastatin co-treated with di-n-pentyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:25055962 dipentyl phthalate decreases expression EXP 6480464 di-n-pentyl phthalate results in decreased expression of CYP17A1 mRNA and di-n-pentyl phthalate results in decreased expression of CYP17A1 protein CTD PMID:22112501 more ... dipentyl phthalate decreases activity EXP 6480464 di-n-pentyl phthalate results in decreased activity of CYP17A1 protein CTD PMID:6829050 diquat increases expression ISO Cyp17a1 (Mus musculus) 6480464 Diquat results in increased expression of CYP17A1 mRNA CTD PMID:36851058 disulfiram multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 Disulfiram inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased expression of CYP17A1 mRNA] CTD PMID:22285649 drospirenone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [Ethinyl Estradiol co-treated with drospirenone] results in decreased activity of CYP17A1 protein CTD PMID:17418832 endosulfan increases expression ISO Cyp17a1 (Mus musculus) 6480464 Endosulfan results in increased expression of CYP17A1 mRNA CTD PMID:30502743 enilconazole increases expression ISO Cyp17a1 (Mus musculus) 6480464 enilconazole results in increased expression of CYP17A1 mRNA CTD PMID:30853599 enniatin decreases expression ISO CYP17A1 (Homo sapiens) 6480464 enniatins results in decreased expression of CYP17A1 mRNA CTD PMID:25625232 Enterolactone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 gene SNP affects the susceptibility to [Phytoestrogens results in increased abundance of 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] CTD PMID:16702327 enzacamene multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CYP17A1 mRNA CTD PMID:25607892 epoxiconazole affects expression ISO Cyp17a1 (Mus musculus) 6480464 epoxiconazole affects the expression of CYP17A1 mRNA CTD PMID:35436446 equol decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Equol results in decreased expression of CYP17A1 mRNA CTD PMID:26876617 estrone affects abundance ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the abundance of Estrone CTD PMID:21427057 etoxazole affects expression ISO Cyp17a1 (Mus musculus) 6480464 etoxazole affects the expression of CYP17A1 mRNA CTD PMID:33618463 etoxazole increases expression ISO Cyp17a1 (Mus musculus) 6480464 etoxazole results in increased expression of CYP17A1 mRNA CTD PMID:33618463 farnesyl diphosphate multiple interactions EXP 6480464 farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CYP17A1 mRNA] CTD PMID:21918126 fenarimol increases expression ISO Cyp17a1 (Mus musculus) 6480464 fenarimol results in increased expression of CYP17A1 mRNA and fenarimol results in increased expression of CYP17A1 protein CTD PMID:21722721 fenvalerate decreases expression ISO Cyp17a1 (Mus musculus) 6480464 fenvalerate results in decreased expression of CYP17A1 mRNA and fenvalerate results in decreased expression of CYP17A1 protein CTD PMID:20063364 and PMID:20138952 fenvalerate multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP17A1 mRNA more ... CTD PMID:33051911 more ... fluconazole affects activity ISO CYP17A1 (Homo sapiens) 6480464 Fluconazole affects the activity of CYP17A1 protein CTD PMID:31330226 flufenoxuron increases expression ISO Cyp17a1 (Mus musculus) 6480464 flufenoxuron results in increased expression of CYP17A1 mRNA CTD PMID:33771252 flurbiprofen decreases activity ISO CYP17A1 (Homo sapiens) 6480464 Flurbiprofen results in decreased activity of CYP17A1 protein CTD PMID:31184881 flurbiprofen decreases activity EXP 6480464 Flurbiprofen results in decreased activity of CYP17A1 protein CTD PMID:31184881 flutamide increases expression ISO Cyp17a1 (Mus musculus) 6480464 Flutamide results in increased expression of CYP17A1 mRNA CTD PMID:11509743 flutamide multiple interactions EXP 6480464 [Dienestrol co-treated with Flutamide] results in increased expression of CYP17A1 mRNA CTD PMID:32738380 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CYP17A1 mRNA CTD PMID:14967917 more ... flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYP17A1 mRNA CTD PMID:24136188 folic acid decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Folic Acid results in decreased expression of CYP17A1 mRNA CTD PMID:25629700 fulvestrant increases expression ISO Cyp17a1 (Mus musculus) 6480464 fulvestrant results in increased expression of CYP17A1 mRNA CTD PMID:17158782 fulvestrant multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [bisphenol A results in increased expression of CYP17A1 mRNA] and Fulvestrant inhibits the reaction [bisphenol A results in increased expression of CYP17A1 protein] CTD PMID:34537452 fulvestrant multiple interactions EXP 6480464 Fulvestrant inhibits the reaction [Estradiol affects the expression of CYP17A1 mRNA] CTD PMID:36931579 fulvestrant multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 fulvestrant inhibits the reaction [DDT results in increased expression of CYP17A1 mRNA] CTD PMID:23684557 fumonisin B1 decreases expression ISO Cyp17a1 (Mus musculus) 6480464 fumonisin B1 results in decreased expression of CYP17A1 mRNA CTD PMID:16221962 galaxolide decreases activity ISO CYP17A1 (Homo sapiens) 6480464 galaxolide results in decreased activity of CYP17A1 protein CTD PMID:23084589 galaxolide decreases expression EXP 6480464 galaxolide results in decreased expression of CYP17A1 mRNA CTD PMID:37797914 galaxolide increases activity ISO CYP17A1 (Homo sapiens) 6480464 galaxolide results in increased activity of CYP17A1 protein CTD PMID:23084589 galaxolide multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [galaxolide co-treated with Cyclic AMP] results in decreased activity of CYP17A1 protein and [galaxolide co-treated with Cyclic AMP] results in increased activity of CYP17A1 protein CTD PMID:23084589 gamma-hexachlorocyclohexane multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Hexachlorocyclohexane inhibits the reaction [Colforsin results in increased expression of CYP17A1 mRNA] CTD PMID:17080404 geldanamycin increases expression ISO Cyp17a1 (Mus musculus) 6480464 geldanamycin results in increased expression of CYP17A1 mRNA CTD PMID:15711029 genistein decreases expression EXP 6480464 Genistein results in decreased expression of CYP17A1 mRNA CTD PMID:15901920 genistein affects expression EXP 6480464 Genistein affects the expression of CYP17A1 mRNA CTD PMID:32827888 genistein decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Genistein results in decreased expression of CYP17A1 mRNA CTD PMID:21624456 and PMID:26792615 genistein increases expression ISO Cyp17a1 (Mus musculus) 6480464 Genistein results in increased expression of CYP17A1 mRNA CTD PMID:18281260 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CYP17A1 mRNA CTD PMID:22061828 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CYP17A1 mRNA CTD PMID:24136188 glyphosate increases expression ISO Cyp17a1 (Mus musculus) 6480464 Glyphosate results in increased expression of CYP17A1 protein CTD PMID:37208198 glyphosate decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Glyphosate results in decreased expression of CYP17A1 mRNA CTD PMID:33957581 herbicide increases expression EXP 6480464 Herbicides results in increased expression of CYP17A1 mRNA CTD PMID:30268827 hexane affects expression EXP 6480464 n-hexane affects the expression of CYP17A1 mRNA and n-hexane affects the expression of CYP17A1 protein CTD PMID:26410608 hexane affects methylation EXP 6480464 n-hexane affects the methylation of CYP17A1 promoter CTD PMID:26410608 HT-2 toxin decreases expression ISO CYP17A1 (Homo sapiens) 6480464 HT-2 toxin results in decreased expression of CYP17A1 mRNA CTD PMID:22982764 hydrazine increases expression EXP 6480464 hydrazine results in increased expression of CYP17A1 mRNA CTD PMID:15370871 hydroquinone O-beta-D-glucopyranoside decreases expression EXP 6480464 Arbutin results in decreased expression of CYP17A1 mRNA and Arbutin results in decreased expression of CYP17A1 protein CTD PMID:37783241 hydroxyflutamide increases expression ISO CYP17A1 (Homo sapiens) 6480464 hydroxyflutamide results in increased expression of CYP17A1 mRNA CTD PMID:29556062 imidacloprid decreases expression EXP 6480464 imidacloprid results in decreased expression of CYP17A1 mRNA CTD PMID:27782041 and PMID:34171690 imidacloprid multiple interactions EXP 6480464 Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP17A1 mRNA] CTD PMID:34171690 imidacloprid decreases expression ISO Cyp17a1 (Mus musculus) 6480464 imidacloprid results in decreased expression of CYP17A1 mRNA CTD PMID:31780179 inulin multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CYP17A1 mRNA CTD PMID:36331819 iodoacetic acid decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Iodoacetic Acid results in decreased expression of CYP17A1 mRNA CTD PMID:31693920 isoflavones increases activity EXP 6480464 Isoflavones results in increased activity of CYP17A1 protein CTD PMID:15698548 isoflavones multiple interactions EXP 6480464 Isoflavones inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of CYP17A1 protein] CTD PMID:34197824 isoliquiritigenin decreases expression ISO Cyp17a1 (Mus musculus) 6480464 isoliquiritigenin results in decreased expression of CYP17A1 mRNA CTD PMID:27773742 ketoconazole multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Ketoconazole inhibits the reaction [Colforsin results in increased expression of CYP17A1 mRNA] CTD PMID:16935330 ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of CYP17A1 mRNA CTD PMID:36653537 ketoconazole decreases activity EXP 6480464 Ketoconazole results in decreased activity of CYP17A1 protein CTD PMID:15934942 and PMID:25993309 ketoconazole decreases activity ISO CYP17A1 (Homo sapiens) 6480464 Ketoconazole results in decreased activity of CYP17A1 protein CTD PMID:11118046 more ... ketoconazole decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Ketoconazole results in decreased expression of CYP17A1 mRNA CTD PMID:16935330 lamotrigine decreases activity ISO CYP17A1 (Homo sapiens) 6480464 lamotrigine results in decreased activity of CYP17A1 protein CTD PMID:15730543 lead diacetate increases expression ISO Cyp17a1 (Mus musculus) 6480464 lead acetate results in increased expression of CYP17A1 mRNA CTD PMID:21335049 lead diacetate decreases expression ISO Cyp17a1 (Mus musculus) 6480464 lead acetate results in decreased expression of CYP17A1 mRNA and lead acetate results in decreased expression of CYP17A1 protein CTD PMID:22806249 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of CYP17A1 mRNA CTD PMID:24136188 letrozole increases expression EXP 6480464 Letrozole results in increased expression of CYP17A1 mRNA CTD PMID:32298659 letrozole decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Letrozole results in decreased expression of CYP17A1 mRNA CTD PMID:37254606 letrozole increases expression ISO Cyp17a1 (Mus musculus) 6480464 Letrozole results in increased expression of CYP17A1 mRNA CTD PMID:37030623 letrozole multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Letrozole co-treated with tris(2 more ... CTD PMID:37030623 and PMID:37254606 letrozole multiple interactions EXP 6480464 Metformin inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA] more ... CTD PMID:32298659 levetiracetam decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Levetiracetam results in decreased expression of CYP17A1 mRNA CTD PMID:19566492 levonorgestrel multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CYP17A1 mRNA CTD PMID:19074003 linuron decreases expression EXP 6480464 Linuron results in decreased expression of CYP17A1 mRNA CTD PMID:28007637 and PMID:28705778 lipopolysaccharide decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of CYP17A1 mRNA and Lipopolysaccharides results in decreased expression of CYP17A1 protein CTD PMID:8828518 lipopolysaccharide increases expression ISO Cyp17a1 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of CYP17A1 mRNA CTD PMID:27339419 lipopolysaccharide multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Lipopolysaccharides results in decreased expression of CYP17A1 protein] which results in decreased abundance of Testosterone CTD PMID:8828518 luteolin decreases expression EXP 6480464 Luteolin results in decreased expression of CYP17A1 mRNA CTD PMID:31201582 mestranol decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Mestranol results in decreased expression of CYP17A1 mRNA CTD PMID:36098747 metformin decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Metformin results in decreased expression of CYP17A1 mRNA CTD PMID:23166782 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA] CTD PMID:32298659 metformin affects expression EXP 6480464 Metformin affects the expression of CYP17A1 mRNA CTD PMID:31324951 methidathion increases expression ISO Cyp17a1 (Mus musculus) 6480464 methidathion results in increased expression of CYP17A1 mRNA CTD PMID:34813904 methotrexate affects expression ISO Cyp17a1 (Mus musculus) 6480464 Methotrexate affects the expression of CYP17A1 mRNA CTD PMID:18502557 methoxyacetic acid increases expression ISO Cyp17a1 (Mus musculus) 6480464 methoxyacetic acid results in increased expression of CYP17A1 mRNA CTD PMID:18486176 methoxychlor multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Estradiol co-treated with Methoxychlor metabolite] results in decreased expression of CYP17A1 mRNA CTD PMID:11509743 methoxychlor decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Methoxychlor metabolite results in decreased expression of CYP17A1 mRNA and Methoxychlor results in decreased expression of CYP17A1 mRNA CTD PMID:11509743 and PMID:21514315 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of CYP17A1 mRNA CTD PMID:30744511 metyrapone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Metyrapone inhibits the reaction [Colforsin results in increased expression of CYP17A1 mRNA] CTD PMID:16935330 miconazole decreases activity ISO CYP17A1 (Homo sapiens) 6480464 Miconazole results in decreased activity of CYP17A1 protein CTD PMID:31330226 Mitotane decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Mitotane results in decreased expression of CYP17A1 mRNA CTD PMID:23254310 Mitotane multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA] CTD PMID:22546480 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of CYP17A1 mRNA CTD PMID:16809437 mono(2-ethylhexyl) phthalate multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:31884101 mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of CYP17A1 mRNA and mono-(2-ethylhexyl)phthalate results in decreased expression of CYP17A1 protein CTD PMID:16809437 and PMID:22087261 mono(2-ethylhexyl) phthalate affects expression EXP 6480464 mono-(2-ethylhexyl)phthalate affects the expression of CYP17A1 CTD PMID:19560483 monobenzyl phthalate multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:31884101 Monobutylphthalate decreases expression EXP 6480464 monobutyl phthalate results in decreased expression of CYP17A1 mRNA CTD PMID:22511013 monoethyl phthalate multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP17A1 mRNA CTD PMID:31884101 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CYP17A1 mRNA CTD PMID:21515302 mycotoxin increases expression ISO CYP17A1 (Homo sapiens) 6480464 Mycotoxins results in increased expression of CYP17A1 mRNA CTD PMID:23665424 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 mRNA] and Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 protein] CTD PMID:29567110 N-ethyl-N-nitrosourea increases mutagenesis ISO Cyp17a1 (Mus musculus) 6480464 Ethylnitrosourea results in increased mutagenesis of CYP17A1 mRNA CTD PMID:27776689 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP17A1 mRNA and [nodularin co-treated with Diethylnitrosamine] results in decreased activity of CYP17A1 protein CTD PMID:12112309 and PMID:17602206 N-nitrosodiethylamine increases expression ISO Cyp17a1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CYP17A1 mRNA CTD PMID:24535843 N-nitrosodiethylamine decreases activity EXP 6480464 Diethylnitrosamine results in decreased activity of CYP17A1 protein CTD PMID:12112309 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of CYP17A1 mRNA CTD PMID:17072980 naringin multiple interactions EXP 6480464 naringin inhibits the reaction [Acrylamide results in decreased expression of CYP17A1 mRNA] CTD PMID:36598108 nickel sulfate multiple interactions EXP 6480464 [CGA protein co-treated with nickel sulfate] results in decreased expression of CYP17A1 mRNA more ... CTD PMID:29567110 nickel sulfate decreases expression EXP 6480464 nickel sulfate results in decreased expression of CYP17A1 mRNA and nickel sulfate results in decreased expression of CYP17A1 protein CTD PMID:29567110 nicotinamide multiple interactions EXP 6480464 Niacinamide inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA] CTD PMID:32298659 nicotine decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Nicotine results in decreased expression of CYP17A1 mRNA CTD PMID:24709674 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of CYP17A1 mRNA and Nicotine results in decreased expression of CYP17A1 protein CTD PMID:27782041 and PMID:28986172 Nodularin multiple interactions EXP 6480464 [nodularin co-treated with Diethylnitrosamine] results in decreased activity of CYP17A1 protein CTD PMID:12112309 oxycodone affects expression EXP 6480464 Oxycodone affects the expression of CYP17A1 mRNA CTD PMID:20487198 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of CYP17A1 mRNA CTD PMID:23439660 ozone decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Ozone results in decreased expression of CYP17A1 mRNA CTD PMID:16183385 p-tert-Amylphenol multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CYP17A1 mRNA CTD PMID:29029336 p-tert-Amylphenol decreases expression ISO Cyp17a1 (Mus musculus) 6480464 4-tert-octylphenol results in decreased expression of CYP17A1 mRNA CTD PMID:17696135 paracetamol multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP17A1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP17A1 mRNA] CTD PMID:17585979 paracetamol multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CYP17A1 mRNA CTD PMID:25607892 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CYP17A1 mRNA CTD PMID:17202762 and PMID:30723492 paracetamol affects expression ISO Cyp17a1 (Mus musculus) 6480464 Acetaminophen affects the expression of CYP17A1 mRNA CTD PMID:17562736 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CYP17A1 mRNA and Paraquat results in decreased expression of CYP17A1 protein CTD PMID:31128353 and PMID:31610511 parathion increases expression ISO Cyp17a1 (Mus musculus) 6480464 Parathion results in increased expression of CYP17A1 mRNA CTD PMID:34813904 PCB138 multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 pentachlorophenol decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Pentachlorophenol results in decreased expression of CYP17A1 mRNA CTD PMID:21296122 pentachlorophenol increases expression ISO Cyp17a1 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of CYP17A1 mRNA CTD PMID:23892564 perflubron increases expression ISO CYP17A1 (Homo sapiens) 6480464 perflubron results in increased expression of CYP17A1 mRNA CTD PMID:25871633 perfluorododecanoic acid decreases expression EXP 6480464 perfluorododecanoic acid results in decreased expression of CYP17A1 mRNA and perfluorododecanoic acid results in decreased expression of CYP17A1 protein CTD PMID:17400581 more ... perfluorononanoic acid increases expression ISO Cyp17a1 (Mus musculus) 6480464 perfluoro-n-nonanoic acid results in increased expression of CYP17A1 mRNA CTD PMID:25543169 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CYP17A1 mRNA CTD PMID:16221955 more ... perfluorooctane-1-sulfonic acid multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [CYP17A1 gene SNP affects the susceptibility to perfluorooctane sulfonic acid] which affects the abundance of Androstenedione and [CYP17A1 gene SNP affects the susceptibility to perfluorooctane sulfonic acid] which affects the abundance of Testosterone CTD PMID:34536543 perfluorooctane-1-sulfonic acid multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP17A1 mRNA more ... CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO CYP17A1 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP17A1 mRNA CTD PMID:23074026 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP17A1 mRNA CTD PMID:16221955 more ... perfluorooctanoic acid decreases expression ISO Cyp17a1 (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of CYP17A1 mRNA and perfluorooctanoic acid results in decreased expression of CYP17A1 protein CTD PMID:20118188 more ... perfluorooctanoic acid increases expression ISO Cyp17a1 (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of CYP17A1 mRNA CTD PMID:17681415 perfluorooctanoic acid multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 Dietary Fats more ... CTD PMID:23626681 and PMID:29721586 perfluoroundecanoic acid decreases expression EXP 6480464 perfluoroundecanoic acid results in decreased expression of CYP17A1 mRNA and perfluoroundecanoic acid results in decreased expression of CYP17A1 protein CTD PMID:33549592 and PMID:35143807 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of CYP17A1 mRNA CTD PMID:31324951 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP17A1 mRNA CTD PMID:19162173 phenobarbital increases expression ISO Cyp17a1 (Mus musculus) 6480464 Phenobarbital results in increased expression of CYP17A1 mRNA CTD PMID:19270015 and PMID:23091169 phytoestrogen multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 gene SNP affects the susceptibility to [Phytoestrogens results in increased abundance of 2 more ... CTD PMID:16702327 pioglitazone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 pioglitazone inhibits the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased activity of CYP17A1 protein] and pioglitazone inhibits the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of CYP17A1 mRNA] CTD PMID:17138841 pioglitazone decreases expression ISO CYP17A1 (Homo sapiens) 6480464 pioglitazone results in decreased expression of CYP17A1 mRNA CTD PMID:17138841 pioglitazone decreases activity ISO CYP17A1 (Homo sapiens) 6480464 pioglitazone results in decreased activity of CYP17A1 protein CTD PMID:15072549 and PMID:17138841 piperonyl butoxide decreases expression EXP 6480464 Piperonyl Butoxide results in decreased expression of CYP17A1 mRNA CTD PMID:22484513 pirinixic acid multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of CYP17A1 mRNA] CTD PMID:20059764 pirinixic acid multiple interactions EXP 6480464 pirinixic acid promotes the reaction [PPARA protein binds to CYP17A1 promoter] CTD PMID:23358192 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CYP17A1 mRNA CTD PMID:19162173 more ... pirinixic acid increases expression ISO Cyp17a1 (Mus musculus) 6480464 pirinixic acid results in increased expression of CYP17A1 mRNA CTD PMID:18301758 and PMID:20059764 potassium dichromate multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CYP17A1 protein CTD PMID:33675932 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of CYP17A1 protein CTD PMID:30315952 pregnenolone affects metabolic processing ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the metabolism of Pregnenolone CTD PMID:16030167 and PMID:16054388 pregnenolone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [[abiraterone results in decreased activity of CYP17A1 protein] which results in decreased hydroxylation of Pregnenolone] which results in increased chemical synthesis of 17-alpha-Hydroxypregnenolone more ... CTD PMID:17194026 and PMID:29100959 pregnenolone increases hydroxylation ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein mutant form results in increased hydroxylation of Pregnenolone and CYP17A1 protein results in increased hydroxylation of Pregnenolone CTD PMID:15562394 more ... pregnenolone multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Pregnenolone binds to CYP17A1 protein] CTD PMID:15666820 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP17A1 mRNA CTD PMID:19162173 prochloraz decreases activity ISO CYP17A1 (Homo sapiens) 6480464 prochloraz results in decreased activity of CYP17A1 protein CTD PMID:19733639 prochloraz decreases expression ISO CYP17A1 (Homo sapiens) 6480464 prochloraz results in decreased expression of CYP17A1 mRNA CTD PMID:19733639 and PMID:25324206 prochloraz multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 prochloraz results in decreased expression of and results in decreased activity of CYP17A1 protein CTD PMID:25324206 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of CYP17A1 mRNA and prochloraz results in increased expression of CYP17A1 protein CTD PMID:16375936 prochloraz multiple interactions EXP 6480464 [prochloraz results in decreased activity of CYP17A1 protein] which results in decreased chemical synthesis of Testosterone CTD PMID:17234647 and PMID:17369198 prochloraz decreases activity EXP 6480464 prochloraz results in decreased activity of CYP17A1 protein CTD PMID:16375936 more ... profenofos increases expression EXP 6480464 profenofos results in increased expression of CYP17A1 mRNA CTD PMID:17569032 progesterone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [[abiraterone results in decreased activity of CYP17A1 protein] which results in decreased hydroxylation of Progesterone] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone more ... CTD PMID:14522586 more ... progesterone multiple interactions EXP 6480464 [[3 more ... CTD PMID:19603415 progesterone increases hydroxylation ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein results in increased hydroxylation of Progesterone CTD PMID:15562394 more ... progesterone affects metabolic processing ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the metabolism of Progesterone CTD PMID:16030167 and PMID:16054388 progesterone affects metabolic processing EXP 6480464 CYP17A1 protein affects the metabolism of Progesterone CTD PMID:15261307 prostaglandin E2 increases expression ISO CYP17A1 (Homo sapiens) 6480464 Dinoprostone results in increased expression of CYP17A1 mRNA CTD PMID:19001523 pyrethrins increases expression EXP 6480464 Pyrethrins results in increased expression of CYP17A1 mRNA CTD PMID:36053783 pyrethrins affects expression EXP 6480464 Pyrethrins affects the expression of CYP17A1 mRNA CTD PMID:34896426 pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of CYP17A1 protein CTD PMID:34896426 pyruvic acid multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Pyruvic Acid promotes the reaction [CTBP1 protein binds to CYP17A1 promoter] more ... CTD PMID:18184656 pyruvic acid increases expression ISO CYP17A1 (Homo sapiens) 6480464 Pyruvic Acid results in increased expression of CYP17A1 mRNA CTD PMID:18184656 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [[Atrazine co-treated with Bucladesine] results in increased expression of CYP17A1 mRNA] more ... CTD PMID:23200735 and PMID:29710542 resveratrol multiple interactions EXP 6480464 [[resveratrol analog co-treated with CGA protein] results in decreased expression of CYP17A1 protein] which results in increased secretion of Progesterone more ... CTD PMID:19603415 and PMID:24524197 resveratrol multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP17A1 mRNA CTD PMID:23557933 resveratrol decreases expression ISO CYP17A1 (Homo sapiens) 6480464 resveratrol analog results in decreased expression of CYP17A1 mRNA and resveratrol results in decreased expression of CYP17A1 mRNA CTD PMID:24610083 and PMID:24875446 resveratrol decreases activity ISO CYP17A1 (Homo sapiens) 6480464 resveratrol analog results in decreased activity of CYP17A1 protein and resveratrol results in decreased activity of CYP17A1 protein CTD PMID:24610083 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CYP17A1 mRNA CTD PMID:22719052 and PMID:24524197 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYP17A1 mRNA CTD PMID:28374803 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 mRNA] and SB 203580 inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 protein] CTD PMID:29567110 sertraline decreases expression EXP 6480464 Sertraline results in decreased expression of CYP17A1 mRNA CTD PMID:29850907 simvastatin multiple interactions EXP 6480464 [Simvastatin co-treated with di-n-pentyl phthalate] results in decreased expression of CYP17A1 mRNA more ... CTD PMID:21918126 more ... simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of CYP17A1 mRNA CTD PMID:21918126 and PMID:24524197 sodium arsenite decreases expression ISO Cyp17a1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of CYP17A1 mRNA and sodium arsenite results in decreased expression of CYP17A1 protein CTD PMID:28414027 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CYP17A1 mRNA and sodium arsenite results in decreased expression of CYP17A1 protein CTD PMID:30557709 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of CYP17A1 mRNA CTD PMID:25993096 sphingosine increases expression ISO CYP17A1 (Homo sapiens) 6480464 Sphingosine results in increased expression of CYP17A1 mRNA CTD PMID:15666826 sphingosine 1-phosphate increases expression ISO CYP17A1 (Homo sapiens) 6480464 sphingosine 1-phosphate results in increased expression of CYP17A1 mRNA CTD PMID:15666826 T-2 toxin multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [T-2 Toxin co-treated with CGA protein] results in decreased activity of CYP17A1 protein CTD PMID:25962641 tamoxifen decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Tamoxifen results in decreased expression of CYP17A1 mRNA CTD PMID:25123088 tamoxifen multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of CYP17A1 mRNA CTD PMID:17630414 tamoxifen affects expression ISO Cyp17a1 (Mus musculus) 6480464 Tamoxifen affects the expression of CYP17A1 mRNA CTD PMID:20937368 tamoxifen increases response to substance ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 gene polymorphism results in increased susceptibility to Tamoxifen CTD PMID:15706422 terbutylazine decreases expression ISO Cyp17a1 (Mus musculus) 6480464 terbutylazine results in decreased expression of CYP17A1 mRNA CTD PMID:23591565 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CYP17A1 mRNA CTD PMID:21515302 testosterone affects abundance ISO CYP17A1 (Homo sapiens) 6480464 CYP17A1 protein affects the abundance of Testosterone CTD PMID:21427057 testosterone multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [CYP17A1 gene SNP affects the susceptibility to perfluorooctane sulfonic acid] which affects the abundance of Testosterone CTD PMID:34536543 testosterone multiple interactions EXP 6480464 [bisphenol A results in decreased expression of CYP17A1 protein] which results in decreased abundance of Testosterone more ... CTD PMID:14605012 more ... testosterone decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Testosterone results in decreased expression of CYP17A1 mRNA CTD PMID:20600201 and PMID:21669218 testosterone affects chemical synthesis ISO Cyp17a1 (Mus musculus) 6480464 CYP17A1 protein affects the chemical synthesis of Testosterone CTD PMID:15932923 testosterone multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [[titanium dioxide results in decreased expression of CYP17A1 mRNA] co-treated with [titanium dioxide results in decreased expression of HSD17B10 mRNA]] results in increased chemical synthesis of Testosterone more ... CTD PMID:14630719 more ... testosterone decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Testosterone results in decreased expression of CYP17A1 mRNA CTD PMID:15625562 testosterone enanthate multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of CYP17A1 mRNA and [cetrorelix co-treated with testosterone enanthate] results in decreased expression of CYP17A1 mRNA CTD PMID:18160741 testosterone enanthate decreases expression EXP 6480464 testosterone enanthate results in decreased expression of CYP17A1 mRNA CTD PMID:21427060 and PMID:25603467 Testosterone propionate decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Testosterone Propionate results in decreased expression of CYP17A1 mRNA CTD PMID:15601916 testosterone undecanoate decreases expression ISO CYP17A1 (Homo sapiens) 6480464 testosterone undecanoate results in decreased expression of CYP17A1 mRNA CTD PMID:19074003 testosterone undecanoate multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CYP17A1 mRNA CTD PMID:19074003 tetrachloroethene increases expression ISO Cyp17a1 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of CYP17A1 mRNA CTD PMID:28973375 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP17A1 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of CYP17A1 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP17A1 mRNA] CTD PMID:31150632 tetracycline decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Tetracycline results in decreased expression of CYP17A1 mRNA CTD PMID:16917069 tetraphene increases expression EXP 6480464 benz(a)anthracene results in increased expression of CYP17A1 mRNA CTD PMID:23358148 tetraphene multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYP17A1 mRNA CTD PMID:27858113 tetraphene decreases expression ISO Cyp17a1 (Mus musculus) 6480464 benz(a)anthracene results in decreased expression of CYP17A1 mRNA CTD PMID:26377693 thiamethoxam multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP17A1 mRNA] CTD PMID:34181816 thiamethoxam decreases expression EXP 6480464 Thiamethoxam results in decreased expression of CYP17A1 mRNA CTD PMID:34181816 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP17A1 mRNA CTD PMID:34492290 thymol multiple interactions EXP 6480464 Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP17A1 mRNA] CTD PMID:34171690 thymol sulfate(1-) multiple interactions EXP 6480464 Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP17A1 mRNA] CTD PMID:34171690 titanium dioxide increases expression ISO Cyp17a1 (Mus musculus) 6480464 titanium dioxide results in increased expression of CYP17A1 mRNA CTD PMID:23131501 titanium dioxide multiple interactions ISO Cyp17a1 (Mus musculus) 6480464 [[titanium dioxide results in decreased expression of CYP17A1 mRNA] co-treated with [titanium dioxide results in decreased expression of HSD17B10 mRNA]] results in increased chemical synthesis of Testosterone CTD PMID:24241477 titanium dioxide decreases expression ISO Cyp17a1 (Mus musculus) 6480464 titanium dioxide results in decreased expression of CYP17A1 mRNA and titanium dioxide results in decreased expression of CYP17A1 protein CTD PMID:24241477 topiramate decreases activity ISO CYP17A1 (Homo sapiens) 6480464 topiramate results in decreased activity of CYP17A1 protein CTD PMID:15730543 torcetrapib increases expression ISO CYP17A1 (Homo sapiens) 6480464 torcetrapib results in increased expression of CYP17A1 mRNA CTD PMID:28235592 tramadol decreases activity ISO CYP17A1 (Homo sapiens) 6480464 Tramadol results in decreased activity of CYP17A1 protein CTD PMID:29100959 trans-cinnamic acid decreases activity ISO CYP17A1 (Homo sapiens) 6480464 cinnamic acid analog results in decreased activity of CYP17A1 protein CTD PMID:15072549 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of CYP17A1 mRNA and tributyltin results in decreased expression of CYP17A1 protein CTD PMID:35430282 trichlorfon decreases activity EXP 6480464 Trichlorfon results in decreased activity of CYP17A1 protein CTD PMID:37419161 trichlorfon decreases expression EXP 6480464 Trichlorfon results in decreased expression of CYP17A1 mRNA CTD PMID:37419161 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CYP17A1 mRNA CTD PMID:33387578 triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of CYP17A1 mRNA CTD PMID:19118620 triphenyl phosphate decreases expression ISO Cyp17a1 (Mus musculus) 6480464 triphenyl phosphate results in decreased expression of CYP17A1 mRNA CTD PMID:26049154 and PMID:26183808 triphenyl phosphate multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 triphenyl phosphate inhibits the reaction [CGB3 protein results in increased expression of CYP17A1 mRNA] CTD PMID:26049154 triphenylstannane multiple interactions EXP 6480464 [triphenyltin co-treated with ethylene dimethanesulfonate] affects the expression of CYP17A1 mRNA CTD PMID:30772500 Triptolide decreases expression ISO Cyp17a1 (Mus musculus) 6480464 triptolide results in decreased expression of CYP17A1 mRNA CTD PMID:32835833 Triptolide multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 [Colforsin co-treated with triptolide] results in decreased expression of CYP17A1 mRNA CTD PMID:31557376 triptonide increases expression ISO Cyp17a1 (Mus musculus) 6480464 triptonide results in increased expression of CYP17A1 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate decreases expression ISO CYP17A1 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate results in decreased expression of CYP17A1 mRNA CTD PMID:29024780 tris(2-chloroethyl) phosphate multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 tris(chloroethyl)phosphate inhibits the reaction [CGB3 protein results in increased expression of CYP17A1 mRNA] CTD PMID:26049154 tris(2-chloroethyl) phosphate decreases expression ISO Cyp17a1 (Mus musculus) 6480464 tris(chloroethyl)phosphate results in decreased expression of CYP17A1 mRNA CTD PMID:26049154 and PMID:26183808 troglitazone decreases activity ISO CYP17A1 (Homo sapiens) 6480464 troglitazone results in decreased activity of CYP17A1 protein CTD PMID:15072549 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP17A1 mRNA CTD PMID:21515302 uranium atom decreases expression EXP 6480464 Uranium analog results in decreased expression of CYP17A1 mRNA CTD PMID:27544493 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of CYP17A1 mRNA CTD PMID:24136188 valproic acid decreases expression ISO CYP17A1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CYP17A1 mRNA CTD PMID:19566492 and PMID:37505509 valproic acid multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Valproic Acid inhibits the reaction [Colforsin results in increased expression of CYP17A1 mRNA] CTD PMID:20726872 valproic acid increases expression ISO CYP17A1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CYP17A1 mRNA and Valproic Acid results in increased expression of CYP17A1 protein CTD PMID:14576182 valproic acid affects expression ISO Cyp17a1 (Mus musculus) 6480464 Valproic Acid affects the expression of CYP17A1 mRNA CTD PMID:17292431 venlafaxine hydrochloride multiple interactions ISO CYP17A1 (Homo sapiens) 6480464 Venlafaxine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased hydroxylation of Pregnenolone] which results in increased chemical synthesis of 17-alpha-Hydroxypregnenolone] more ... CTD PMID:29100959 venlafaxine hydrochloride decreases activity ISO CYP17A1 (Homo sapiens) 6480464 Venlafaxine Hydrochloride results in decreased activity of CYP17A1 protein CTD PMID:29100959 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYP17A1 mRNA CTD PMID:14967917 and PMID:23160963 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CYP17A1 mRNA CTD PMID:32827888 zearalenone decreases expression ISO Cyp17a1 (Mus musculus) 6480464 Zearalenone results in decreased expression of CYP17A1 mRNA CTD PMID:24512812 zearalenone decreases expression EXP 6480464 Zearalenone results in decreased expression of CYP17A1 mRNA CTD PMID:32858132 ziram decreases expression EXP 6480464 Ziram results in decreased expression of CYP17A1 mRNA and Ziram results in decreased expression of CYP17A1 protein CTD PMID:28973382 and PMID:30422632 ziram decreases activity EXP 6480464 Ziram results in decreased activity of CYP17A1 protein CTD PMID:28973382 ziram affects expression EXP 6480464 Ziram affects the expression of CYP17A1 mRNA and Ziram affects the expression of CYP17A1 protein CTD PMID:29627606